Barchart on MSN14h
This Penny Stock Just Doubled on Clinical Trial Results. Analysts Think It Can Surge 266% From Here.
Biotechnology is a high-risk, high-reward landscape where innovation determines success. Yet, occasionally, a small player ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Lipella Pharmaceuticals Inc.: Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company focused on developing innovative therapies ...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Lipella Pharmaceuticals LIPO shares increased by 158.9% to $6.68 during Thursday's pre-market session. The market value of their outstanding shares is at $8.0 million. MBX Biosciences MBX stock moved ...